Compass Inc
F:91D
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Compass Inc
F:91D
|
US |
|
H
|
Healthcare Trust Of America Inc
F:HT01
|
US |
|
N
|
Northern Trust Corp
XBER:NT4
|
US |
|
D
|
Dakota Gold Corp
F:RR6
|
US |
|
Galderma Group AG
F:PY30
|
CH |
|
Aya Gold & Silver Inc
NASDAQ:AYA
|
CA |
|
G
|
George Weston Ltd
OTC:WNGRF
|
CA |
|
C
|
Coloplast A/S
F:CBH
|
DK |
Wall St Price Targets
91D Price Targets Summary
Compass Inc
According to Wall Street analysts, the average 1-year price target for 91D is 11.3 EUR with a low forecast of 7.69 EUR and a high forecast of 15.1 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 91D's stock price target?
Price Target
11.3
EUR
According to Wall Street analysts, the average 1-year price target for 91D is 11.3 EUR with a low forecast of 7.69 EUR and a high forecast of 15.1 EUR.
What is the Revenue forecast for Compass Inc?
Projected CAGR
33%
Over the last 8 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 3 years is 33%.
What is the Gross Profit forecast for Compass Inc?
Projected CAGR
75%
Over the last 8 years, the compound annual growth rate for Gross Profit has been 42%. The projected CAGR for the next 2 years is 75%.